Covid19
Showing NaN - NaN of 16
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Recruiting
- Covid19
- theraputic heparin
- +4 more
-
Birmingham, Alabama
- +101 more
Jun 28, 2022
Covid19 Trial in Worldwide (Novaferon, Placebo)
Recruiting
- Covid19
- Novaferon
- Placebo
-
Bahia Blanca, Argentina
- +87 more
Jun 1, 2022
Covid19 Trial in Porto Alegre, Rio De Janeiro, Natal (ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca), CoronaVac (Sinovac
Not yet recruiting
- Covid19
- ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca)
- +2 more
-
Porto Alegre, Rio De Grande Do Sul, Brazil
- +2 more
Oct 19, 2021
Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage
Completed
- Covid19
- +2 more
- No intervention performed
-
Porto Alegre, RS, BrazilHospital de Clínicas de Porto Alegre
Jul 16, 2021
Covid19 Trial in Worldwide (Trimodulin, Placebo (human albumin 1%))
Active, not recruiting
- Covid19
- Trimodulin
- Placebo (human albumin 1%)
-
Porto Alegre, Brazil
- +16 more
Jun 15, 2021
Covid19, Hospitalization Trial in Brazil (Data collection)
Enrolling by invitation
- Covid19
- Hospitalization
- Data collection
-
Salvador, Bahia, Brazil
- +12 more
Mar 18, 2021
Covid19 Trial in Porto Alegre (Convalescent Plasma, Best Supportive Care)
Completed
- Covid19
- Convalescent Plasma
- Best Supportive Care
-
Porto Alegre, Rio Grande Do Sul, BrazilHospital de Clínicas de Porto Alegre
Feb 8, 2021
Covid19, Sars-cov 2 Trial in Porto Alegre (Natural Killer Cells infusion)
Not yet recruiting
- Covid19
- Sars-cov 2
- Natural Killer Cells infusion
-
Porto Alegre, RS, BrazilHospital de Clinicas de Porto Alegre
Nov 17, 2020